Read the full article.
3. Inhaled COPD Medications Associated With Negative Postoperative Outcomes in Patients With Early-Stage NSCLC
In a study of veterans undergoing surgery for early-stage non–small cell lung cancer (NSCLC), investigators found that inhaled COPD medications prescribed preoperatively were associated with several adverse postoperative outcomes. This February article reported that patients with a greater number of prescribed inhaled COPD medications had a prolonged hospital length of stay, more major complications, increased 90-day mortality rates, and decreased overall survival. The researchers noted that routine assessment of each medication before elective NSCLC resection could help identify patients at risk of adverse outcomes.
Read the full article.
2. Gabapentinoid Use in COPD Associated With Increased Severe Exacerbation Risk, Study Says
A January article covered findings that associated gabapentinoid use with an increased risk of severe exacerbation in patients with COPD. Gabapentinoids, namely pregabalin and gabapentin, are anticonvulsant drugs used to treat epilepsy and neuropathic pain. Numerous FDA case reports documented severe breathing difficulties among those using gabapentinoids. Consequently, the researchers assessed whether gabapentinoid use was associated with severe exacerbation in patients with COPD who had an approved or off-label indication for them. They associated gabapentinoid use with increased severe COPD exacerbation risk both overall and across the 3 indications of epilepsy, neuropathic pain, and other chronic pain. The peak increase in severe exacerbation risk occurred about 6 months post-continuous gabapentinoid use.
Read the full article.
1. High White Blood Cell Counts Are Associated With Long-Term Acute COPD Exacerbations, Study Says
This year’s top article featured a January study, which found that patients with COPD and high baseline white blood cell counts, especially high neutrophil counts, were more likely to experience long-term AECOPD. The researchers evaluated the predictive value of white blood cell differential counts and inflammatory biomarkers for 3-year AECOPD in Korean patients, finding that higher baseline neutrophil counts, white blood cell counts, and neutrophil/lymphocyte ratio were linked to increased AECOPD risk. The researchers emphasized the need for further prospective studies to confirm these findings and explore the underlying mechanisms.
Read the full article.